$5.42 Billion is the total value of Redmile Group, LLC's 80 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IGMS | IGM BIOSCIENCES INC | $229,512,000 | +30.0% | 3,144,000 | 0.0% | 4.24% | -14.4% | |
| APRE | APREA THERAPEUTICS INC | $87,981,000 | +11.6% | 2,268,718 | 0.0% | 1.62% | -26.5% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $67,084,000 | +45.9% | 4,041,211 | 0.0% | 1.24% | -4.0% | |
| CYRX | CRYOPORT INC | $54,984,000 | +77.2% | 1,817,663 | 0.0% | 1.02% | +16.7% | |
| CABA | CABALETTA BIO INC | $15,884,000 | +52.6% | 1,425,896 | 0.0% | 0.29% | +0.3% | |
| STXS | STEREOTAXIS INC | $13,841,000 | +47.7% | 3,103,327 | 0.0% | 0.26% | -2.7% | |
| ITMR | ITAMAR MED LTDsponsored ads | $11,625,000 | +57.9% | 625,000 | 0.0% | 0.22% | +4.4% | |
| PROF | PROFOUND MED CORP | $6,776,000 | +73.9% | 400,000 | 0.0% | 0.12% | +14.7% | |
| SYRS | SYROS PHARMACEUTICALS INC | $2,263,000 | +79.7% | 212,291 | 0.0% | 0.04% | +20.0% | |
| VAPO | VAPOTHERM INC | $1,025,000 | +117.6% | 25,000 | 0.0% | 0.02% | +46.2% | |
| OVID | OVID THERAPEUTICS INC | $899,000 | +147.7% | 121,950 | 0.0% | 0.02% | +70.0% | |
| ELGXQ | ENDOLOGIX INC | $63,000 | +16.7% | 78,755 | 0.0% | 0.00% | -50.0% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $8,000 | +14.3% | 10,229 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-10 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.